PriceTargets.com logo

Edgewell Personal Care - EPC Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $37.67
  • Forecasted Upside: -0.09%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$37.70 As of 04/23/2024 01:00 AM ET
▲ +0.86 (2.33%)

This chart shows the closing price for EPC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Edgewell Personal Care Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EPC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EPC

Analyst Price Target is $37.67
▼ -0.09% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Edgewell Personal Care in the last 3 months. The average price target is $37.67, with a high forecast of $43.00 and a low forecast of $33.00. The average price target represents a -0.09% upside from the last price of $37.70.

This chart shows the closing price for EPC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 3 contributing investment analysts is to hold stock in Edgewell Personal Care. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
11/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
7/29/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
10/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/12/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$39.00 ➝ $37.00Low
2/8/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$40.00 ➝ $43.00Low
2/8/2024BarclaysUpgradeUnderweight ➝ Equal Weight$39.00Low
1/16/2024BarclaysBoost TargetUnderweight ➝ Underweight$32.00 ➝ $35.00Low
11/10/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$38.00 ➝ $33.00Low
10/12/2023BarclaysLower TargetUnderweight ➝ Underweight$37.00 ➝ $32.00Low
8/7/2023BarclaysBoost TargetUnderweight ➝ Underweight$36.00 ➝ $37.00Low
7/20/2023BarclaysLower TargetUnderweight$40.00 ➝ $36.00Low
5/12/2023BarclaysBoost Target$38.00 ➝ $40.00Low
4/5/2023UBS GroupInitiated CoverageNeutral$47.00Low
2/10/2023BarclaysBoost TargetUnderweight$37.00 ➝ $38.00Low
2/9/2023Royal Bank of CanadaReiterated RatingOutperform$53.00Low
2/9/2023Canaccord Genuity GroupBoost TargetBuy$48.00 ➝ $52.00Low
11/17/2022Canaccord Genuity GroupInitiated CoverageBuy$48.00Low
11/16/2022Canaccord Genuity GroupInitiated CoverageBuyLow
11/16/2022Wells Fargo & CompanyBoost Target$44.00N/A
11/14/2022BarclaysBoost TargetUnderweight$31.00 ➝ $35.00Low
11/11/2022Morgan StanleyLower TargetUnderweight$36.00 ➝ $35.00Low
11/7/2022Wells Fargo & CompanyLower TargetOverweight$46.00 ➝ $43.00Low
10/25/2022The Goldman Sachs GroupDowngradeBuy ➝ Neutral$47.00 ➝ $42.00Low
10/17/2022Morgan StanleyDowngradeEqual Weight ➝ Underweight$40.00 ➝ $36.00Low
8/8/2022BarclaysBoost TargetUnderweight$29.00 ➝ $33.00Low
8/3/2022Wells Fargo & CompanyBoost TargetOverweight$39.00 ➝ $44.00Low
5/12/2022BarclaysLower Target$34.00 ➝ $29.00Low
3/29/2022The Goldman Sachs GroupLower Target$57.00 ➝ $53.00Medium
2/10/2022Morgan StanleyLower TargetEqual Weight$46.00 ➝ $43.00High
2/10/2022BarclaysLower Target$46.00 ➝ $34.00High
2/9/2022Wells Fargo & CompanyLower TargetOverweight$55.00 ➝ $47.00High
1/5/2022Wells Fargo & CompanyUpgradeUnderweight ➝ Overweight$41.00 ➝ $55.00High
11/12/2021Wells Fargo & CompanyBoost TargetUnderweight$37.00 ➝ $41.00High
11/12/2021Royal Bank of CanadaBoost TargetOutperform$52.00 ➝ $55.00High
10/22/2021CitigroupLower TargetNeutral$47.00 ➝ $39.00Low
9/28/2021Wells Fargo & CompanyLower TargetUnderweight$39.00 ➝ $37.00Low
8/6/2021Royal Bank of CanadaBoost TargetOutperform$50.00 ➝ $52.00Medium
7/13/2021Raymond JamesInitiated CoverageMarket PerformLow
5/7/2021Northern Trust Capital MarketsBoost Target$45.00 ➝ $55.00Low
5/7/2021Morgan StanleyBoost TargetEqual Weight$36.00 ➝ $43.00Medium
5/7/2021Royal Bank of CanadaBoost TargetOutperform$45.00 ➝ $50.00Low
5/3/2021Deutsche Bank AktiengesellschaftBoost TargetHold$38.00 ➝ $41.00Medium
12/7/2020Wells Fargo & CompanyInitiated CoverageUnderweight$30.00Medium
11/23/2020Deutsche Bank AktiengesellschaftBoost TargetHold$34.00 ➝ $40.00High
11/19/2020Royal Bank of CanadaBoost TargetOutperform$36.00 ➝ $43.00Low
11/13/2020Deutsche Bank AktiengesellschaftBoost TargetHold$30.00 ➝ $34.00Medium
11/13/2020Morgan StanleyBoost TargetEqual Weight$31.00 ➝ $33.00Medium
10/14/2020Morgan StanleyBoost TargetEqual Weight$29.00 ➝ $31.00Low
8/5/2020Morgan StanleyLower TargetEqual Weight$30.00 ➝ $29.00High
8/5/2020Deutsche Bank AktiengesellschaftLower TargetHold$38.00 ➝ $30.00High
7/13/2020Morgan StanleyBoost TargetEqual Weight$28.00 ➝ $30.00Medium
5/8/2020Morgan StanleyBoost TargetEqual Weight$27.00 ➝ $28.00High
5/8/2020CitigroupLower TargetNeutral$36.00 ➝ $30.00High
2/28/2020The Goldman Sachs GroupInitiated CoverageConviction-Buy$56.00Low
2/19/2020Royal Bank of CanadaReiterated RatingBuy$45.00High
2/12/2020Morgan StanleyBoost TargetEqual Weight$32.00 ➝ $39.00High
2/12/2020BarclaysReiterated RatingSell$33.00High
2/11/2020SunTrust BanksReiterated RatingBuy$45.00High
2/10/2020CitigroupDowngradeBuy ➝ Neutral$38.00 ➝ $43.00High
2/10/2020CfraBoost TargetHold$33.00 ➝ $41.00High
2/10/2020Consumer EdgeUpgradeEqual Weight ➝ OverweightHigh
11/14/2019BarclaysReiterated RatingSell$26.00Medium
10/21/2019Wells Fargo & CompanyReiterated RatingHoldLow
9/3/2019Morgan StanleyLower TargetEqual Weight$35.00 ➝ $32.00Low
8/12/2019BarclaysReiterated RatingSell$27.00High
8/7/2019Royal Bank of CanadaSet TargetBuy$50.00High
8/7/2019Bank of AmericaReiterated RatingNeutral ➝ Neutral$30.00 ➝ $34.00Low
8/7/2019Wells Fargo & CompanyReiterated RatingHold$30.00Low
7/8/2019SunTrust BanksUpgradeHold ➝ Buy$35.00 ➝ $40.00High
5/10/2019SunTrust BanksLower TargetPositive ➝ Hold$35.00Medium
(Data available from 4/24/2019 forward)

News Sentiment Rating

1.34 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 9 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/26/2023
  • 5 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/26/2023
  • 6 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/25/2023
  • 7 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/25/2023
  • 5 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/24/2024
  • 24 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/23/2024
  • 12 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/24/2024
  • 7 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/23/2024

Current Sentiment

  • 7 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Edgewell Personal Care logo
Edgewell Personal Care Company is a manufacturer and marketer of personal care products in the wet shave, sun and skin care, feminine care and infant care categories. As of September 30, 2016, the Company had a portfolio of over 25 brands. It manages its business in four segments: Wet Shave, Sun and Skin Care, Feminine Care and All Other. Its Wet shave products are sold under the Schick, Wilkinson Sword, Edge, Skintimate, Shave Guard and Personna brand names. Its Sun and Skin Care products are sold under the Banana Boat, Hawaiian Tropic, Wet Ones and Playtex brand names and offers Wet Ones, portable hand wipes category, and Playtex household gloves, the branded household glove in the United States. Its Feminine Care segment markets its products under the Playtex, Stayfree, Carefree and o.b. brands and markets pads and liners. Its All Other segment includes infant care, pet care and miscellaneous other products.
Read More

Today's Range

Now: $37.70
Low: $37.01
High: $38.00

50 Day Range

MA: $37.51
Low: $35.33
High: $38.91

52 Week Range

Now: $37.70
Low: $33.71
High: $46.13

Volume

317,113 shs

Average Volume

254,215 shs

Market Capitalization

$1.88 billion

P/E Ratio

18.48

Dividend Yield

1.63%

Beta

0.94

Frequently Asked Questions

What sell-side analysts currently cover shares of Edgewell Personal Care?

The following Wall Street analysts have issued reports on Edgewell Personal Care in the last year: Barclays PLC, Morgan Stanley, StockNews.com, and Wells Fargo & Company.
View the latest analyst ratings for EPC.

What is the current price target for Edgewell Personal Care?

3 Wall Street analysts have set twelve-month price targets for Edgewell Personal Care in the last year. Their average twelve-month price target is $37.67, suggesting a possible downside of 0.1%. Wells Fargo & Company has the highest price target set, predicting EPC will reach $43.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $33.00 for Edgewell Personal Care in the next year.
View the latest price targets for EPC.

What is the current consensus analyst rating for Edgewell Personal Care?

Edgewell Personal Care currently has 1 sell rating, 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in EPC, but not buy more shares or sell existing shares.
View the latest ratings for EPC.

What other companies compete with Edgewell Personal Care?

Other companies that are similar to Edgewell Personal Care include Olaplex, Waldencast, Inter Parfums, Natura &Co and MGP Ingredients. Learn More about companies similar to Edgewell Personal Care.

How do I contact Edgewell Personal Care's investor relations team?

Edgewell Personal Care's physical mailing address is 6 RESEARCH DRIVE, SHELTON CT, 06484. The company's listed phone number is 203-944-5500 and its investor relations email address is [email protected]. The official website for Edgewell Personal Care is www.edgewell.com. Learn More about contacing Edgewell Personal Care investor relations.